Moving the Needle on Healthcare Cost Containment & Reform

Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Today, Pioneer Institute submitted recommendations to the Commonwealth of Massachusetts’ Special Senate Committee on Health Care Cost Containment and Reform. Pioneer applauds provisions of the proposed legislation that would reduce emergency room use and re-admissions, expand scope of practice, and embrace telemedicine. The Committee should also be commended for looking to other states’ accomplishments in this area.

But the current bill raises some concerns. In some instances, we believe it diminishes the potential for greater cost savings by adding unnecessary regulatory burdens. The projected savings relative to 2020 spending are quite modest, at less than 0.2 percent. The Medicaid buy-in program as it is presented is a radical change from the existing program structure – it will require more elaboration and analysis, as it is unclear what the impact of this proposal will be on MassHealth and providers across the Commonwealth. Pioneer also has concerns that the bill could lead to harmful unintended consequences, such as the collapse of the merged private insurance market. We hope the Legislature addresses these issues, but this bill starts an important healthcare cost conversation in Massachusetts, and we commend the Senate for taking the lead in this effort. Read Pioneer’s full letter to the Committee.

Get Updates On Our Healthcare Research and Events!

Related Research

HHS Secretary Alex Azar doesn’t want drug access to become an equation

/
This op-ed by William Smith appeared in the Washington Examiner…

Action on health care pricing transparency needed to stem rising costs

/
The Hill BY JIM STERGIOS AND CHARLES CHIEPPO, OPINION CONTRIBUTORS…

U.S. HHS Secretary Alex Azar to Be Featured Speaker at Pioneer Institute’s 2019 Hewitt Healthcare Lecture

BOSTON – Secretary of the U.S. Department of Health and Human…

Study Finds Patient Cost for MRI Largely Unrelated to Overall Price or Insurer Contribution at 14 MA Hospitals

Read coverage of this report in WCVB-TV, Boston Herald, the Boston…

The U.S. shouldn’t use the ‘QALY’ in drug cost-effectiveness reviews

/
This op-ed by William Smith appeared in STAT News on February…

Baker’s Orwellian drug pricing policy

/
This op-ed by William Smith appeared in Commonwealth Magazine…

Study Urges Caution Before Adopting ICER Reviews to Determine Cost Effectiveness of Treatments

Review methodology could negatively impact elderly, the disabled,…

Study Finds MassHealth’s Enhanced Eligibility Verification Saves $250 Million a Year

Reforms fixed MassHealth's $1.2 billion eligibility crisis, freed…

A Wealth of Data: A Map of the Massachusetts Opioid Epidemic

/
In 2016, the rate of opioid overdose deaths in Massachusetts…

Kudos To CHIA On Major Step Toward Greater Healthcare Price Transparency

Pioneer applauds the Center for Health Information and Analysis…

Report Recommends Alternatives to Drug Pricing Transparency Legislation

/
Value-based reimbursement, focus on middlemen in drug distribution…

Can State Pensioners Pay for Future Medically Necessary Long-term Care?

/
At some point many people find themselves needing help to care…

Bill H.2890: Funding More Problems than Solutions

/
Studies show that 90 percent of the elderly want to live out…

MA Health Insurers Have Made Good Progress in Price Transparency, But Significant Work Remains

Read press coverage of this report in the Boston Business Journal and…

Moving the Needle on Healthcare Cost Containment & Reform

/
Today, Pioneer Institute submitted recommendations to the Commonwealth…